Physician profile
Rita Shats
NPI 1588863401
$8,586.50
in general payments reported to CMS, 2019-2025
16 companies · $1,776 in 2025
The $1,776 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $183 · 2021: $244 · 2022: $1,553 · 2023: $1,536 · 2024: $2,826 · 2025: $1,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,646 · Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,646.00 |
| Food and Beverage | $491.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $7,107.31 | 2022-2025 | Nexplanon, Nuvaring |
| Exeltis, USA INC. | $372.04 | 2019-2025 | Slynd |
| Abbvie INC. | $273.61 | 2019-2022 | |
| Avion Pharmaceuticals | $217.77 | 2019-2021 | |
| Baxter Healthcare | $150.00 | 2025 | Floseal, Tisseel |
| Coopersurgical, INC. | $98.65 | 2021-2023 | Summit Doppler |
| Astellas Pharma US INC | $74.61 | 2024-2025 | Veozah |
| Pfizer INC. | $61.47 | 2021-2024 | |
| Allergan, INC. | $43.33 | 2019 | |
| Merck Sharp & Dohme LLC | $39.06 | 2020-2021 | |
| Therapeuticsmd, INC. | $38.33 | 2019-2020 | |
| Duchesnay USA Incorporated | $34.48 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $28.32 | 2025 | Exparel |
| Hologic Sales and Service, LLC | $17.46 | 2019 | |
| Evofem Biosciences, INC. | $15.59 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $14.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Shats listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.